With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to fully implement the transparent peer review (TPR) process for all new submission from March 15, 2023.
Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Biotarget is among the list of COPE membership.
AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020.
Biotarget welcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.
Biotarget Annual Report (2018)
Biotarget Annual Report (2017)
Welcome to join us on IASLC 18th World Conference on Lung Cancer
Biotarget is a new international peer-reviewed journal devoted to the rapid publication of high-quality studies related to identifying key biotarget molecules and the application of biotarget molecules in human and animal disease, available in print and online.
1 - 8 of 8 Items